Global Heart Attack Diagnostics Market 2022-2026
Technavio has been monitoring the heart attack diagnostics market and it is poised to grow by $ 5.34 bn during 2022-2026, accelerating at a CAGR of 7.51% during the forecast period. Our report on the heart attack diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of cardiac disorders, higher adoption of heart rate tracking devices, and the presence of health awareness programs.
The heart attack diagnostics market analysis includes the end-user segment and geographic landscape.
Technavio's heart attack diagnostics market is segmented as below:
- Ambulatory surgical centers
- Diagnostic centers
By Geographical Landscape
- North America
- Rest of World (ROW)
This study identifies the new product launches coupled with R&D activities as one of the prime reasons driving the heart attack diagnostics market growth during the next few years. Also, the growing presence of OEMs and the increasing number of M&As will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the heart attack diagnostics market covers the following areas:
- Heart attack diagnostics market sizing
- Heart attack diagnostics market forecast
- Heart attack diagnostics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart attack diagnostics market vendors that include Abbott Laboratories, ACS Diagnostics Inc., Asahi Kasei Corp., AstraZeneca Plc, Beckman Coulter Inc., Bio Rad Laboratories Inc., Bionet Co. Ltd., Boston Scientific Corp., Canon Inc., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., General Electric Co., HILL ROM HOLDINGS Inc., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Nihon Kohden Corp, SCHILLER AG, Siemens AG, and Toshiba Corp. Also, the heart attack diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.